Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Last updated: 2022
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2022
- December 20224 results available
- November 20222 results available
- October 20223 results available
- September 20227 results available
- August 202214 results available
- July 20224 results available
- June 202211 results available
- May 20225 results available
- April 20224 results available
- March 202210 results available
- February 20226 results available
- January 20227 results available
Recall class
Displaying 76 - 77 of 77 items.
XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection
AlertHealth professional risk communication | 2022-01-12